Neurosona
PrivateLast Round
M&A
May 3, 2024
Est. Valuation
$6.04M
Total Funding Raised
$1.69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurosona is a medical device company that develops low-intensity focused ultrasound (LIFU) neuromodulation systems for the treatment of brain diseases such as Alzheimer's and major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosona Comparables
Compare Neurosona with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPIRE Therapeutics, Inc. | 82% | |
| Brain Sonix Corporation | 81% | |
| Deepson Bio | 81% | |
Neurosona Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 3, 2024 | ||||
| Corporate Funding | Oct 19, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 39% MoM, reaching 4.8K.
- Apr 19, 2026
Monthly visitors grew 84% MoM, reaching 3.4K.
Neurosona Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurosona's valuation, stock price, and market status.